SG184155A1

SG184155A1 - Ectodomains of influenza matrix 2 protein, expression system, and uses thereof

Ectodomains of influenza matrix 2 protein, expression system, and uses thereof Download PDF

Info

Publication number: SG184155A1
Authority: SG; Singapore
Prior art keywords: seq; polypeptide; polynucleotide; vector; influenza
Prior art date: 2010-03-26

Application number

SG2012069555A

Other languages

English (en)

Inventor

Tina Guina

Michael Lacy

Mario Skiadopoulos

Nutan Mytle

Original Assignee

Emergent Product Dev Gaithersburg Inc

Priority date

2010-03-26

Filing date

2011-03-28

Publication date

2012-10-30

2011-03-28 Application filed by Emergent Product Dev Gaithersburg Inc filed Critical Emergent Product Dev Gaithersburg Inc

2012-10-30 Publication of SG184155A1 publication Critical patent/SG184155A1/en

Links

108090000623 proteins and genes Proteins 0.000 title claims description 121
206010022000 influenza Diseases 0.000 title claims description 120
102000004169 proteins and genes Human genes 0.000 title claims description 81
239000011159 matrix material Substances 0.000 title claims description 37
230000014509 gene expression Effects 0.000 title claims description 24
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 457
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 394
229920001184 polypeptide Polymers 0.000 claims abstract description 316
102000040430 polynucleotide Human genes 0.000 claims abstract description 179
108091033319 polynucleotide Proteins 0.000 claims abstract description 179
239000002157 polynucleotide Substances 0.000 claims abstract description 179
239000000203 mixture Substances 0.000 claims abstract description 134
241001183012 Modified Vaccinia Ankara virus Species 0.000 claims abstract description 132
241000712461 unidentified influenza virus Species 0.000 claims abstract description 92
238000000034 method Methods 0.000 claims abstract description 80
229960005486 vaccine Drugs 0.000 claims abstract description 75
230000028993 immune response Effects 0.000 claims abstract description 61
208000024891 symptom Diseases 0.000 claims abstract description 19
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 15
201000010099 disease Diseases 0.000 claims abstract description 13
230000001939 inductive effect Effects 0.000 claims abstract description 5
210000004027 cell Anatomy 0.000 claims description 144
239000013598 vector Substances 0.000 claims description 131
102000011931 Nucleoproteins Human genes 0.000 claims description 111
108010061100 Nucleoproteins Proteins 0.000 claims description 111
239000012634 fragment Substances 0.000 claims description 84
241000700605 Viruses Species 0.000 claims description 71
241001465754 Metazoa Species 0.000 claims description 68
150000001413 amino acids Chemical class 0.000 claims description 67
241000282414 Homo sapiens Species 0.000 claims description 65
101710154606 Hemagglutinin Proteins 0.000 claims description 63
101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 63
101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 63
101710176177 Protein A56 Proteins 0.000 claims description 63
125000003275 alpha amino acid group Chemical group 0.000 claims description 60
108010006232 Neuraminidase Proteins 0.000 claims description 53
102000005348 Neuraminidase Human genes 0.000 claims description 53
239000000185 hemagglutinin Substances 0.000 claims description 52
239000002671 adjuvant Substances 0.000 claims description 33
230000003053 immunization Effects 0.000 claims description 30
238000002649 immunization Methods 0.000 claims description 30
241000271566 Aves Species 0.000 claims description 27
230000037430 deletion Effects 0.000 claims description 27
238000012217 deletion Methods 0.000 claims description 27
102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 26
108091026890 Coding region Proteins 0.000 claims description 25
108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 25
241000712431 Influenza A virus Species 0.000 claims description 20
230000009385 viral infection Effects 0.000 claims description 19
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 15
241000700618 Vaccinia virus Species 0.000 claims description 15
241000272525 Anas platyrhynchos Species 0.000 claims description 14
230000037452 priming Effects 0.000 claims description 14
210000001744 T-lymphocyte Anatomy 0.000 claims description 13
108020000411 Toll-like receptor Proteins 0.000 claims description 11
102000002689 Toll-like receptor Human genes 0.000 claims description 11
239000002773 nucleotide Substances 0.000 claims description 11
125000003729 nucleotide group Chemical group 0.000 claims description 11
239000013603 viral vector Substances 0.000 claims description 10
230000005875 antibody response Effects 0.000 claims description 9
230000027455 binding Effects 0.000 claims description 9
241000124008 Mammalia Species 0.000 claims description 8
108700026244 Open Reading Frames Proteins 0.000 claims description 8
101710172711 Structural protein Proteins 0.000 claims description 8
239000000463 material Substances 0.000 claims description 8
230000001580 bacterial effect Effects 0.000 claims description 7
150000001875 compounds Chemical class 0.000 claims description 7
238000009472 formulation Methods 0.000 claims description 7
229960003971 influenza vaccine Drugs 0.000 claims description 7
229920001983 poloxamer Polymers 0.000 claims description 7
108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 6
102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 6
241000288906 Primates Species 0.000 claims description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
239000005090 green fluorescent protein Substances 0.000 claims description 6
239000002245 particle Substances 0.000 claims description 6
230000000295 complement effect Effects 0.000 claims description 5
230000021633 leukocyte mediated immunity Effects 0.000 claims description 5
239000002502 liposome Substances 0.000 claims description 5
108010070675 Glutathione transferase Proteins 0.000 claims description 4
102000005720 Glutathione transferase Human genes 0.000 claims description 4
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 claims description 4
102000002933 Thioredoxin Human genes 0.000 claims description 4
108010022394 Threonine synthase Proteins 0.000 claims description 4
241000251539 Vertebrata <Metazoa> Species 0.000 claims description 4
239000011575 calcium Substances 0.000 claims description 4
102000028861 calmodulin binding Human genes 0.000 claims description 4
108091000084 calmodulin binding Proteins 0.000 claims description 4
102000004419 dihydrofolate reductase Human genes 0.000 claims description 4
238000002347 injection Methods 0.000 claims description 4
239000007924 injection Substances 0.000 claims description 4
210000001161 mammalian embryo Anatomy 0.000 claims description 4
229920000642 polymer Polymers 0.000 claims description 4
230000002685 pulmonary effect Effects 0.000 claims description 4
150000003839 salts Chemical class 0.000 claims description 4
108060008226 thioredoxin Proteins 0.000 claims description 4
229940094937 thioredoxin Drugs 0.000 claims description 4
108010041986 DNA Vaccines Proteins 0.000 claims description 3
229940021995 DNA vaccine Drugs 0.000 claims description 3
229910052782 aluminium Inorganic materials 0.000 claims description 3
239000001913 cellulose Substances 0.000 claims description 3
229920002678 cellulose Polymers 0.000 claims description 3
239000000377 silicon dioxide Substances 0.000 claims description 3
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 claims description 2
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 claims description 2
101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 claims description 2
108050001427 Avidin/streptavidin Proteins 0.000 claims description 2
102000004506 Blood Proteins Human genes 0.000 claims description 2
108010017384 Blood Proteins Proteins 0.000 claims description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
229920002101 Chitin Polymers 0.000 claims description 2
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 claims description 2
241000702421 Dependoparvovirus Species 0.000 claims description 2
101710135898 Myc proto-oncogene protein Proteins 0.000 claims description 2
102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 2
241001195348 Nusa Species 0.000 claims description 2
229920000805 Polyaspartic acid Polymers 0.000 claims description 2
101100408135 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnA gene Proteins 0.000 claims description 2
108010088160 Staphylococcal Protein A Proteins 0.000 claims description 2
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
101710150448 Transcriptional regulator Myc Proteins 0.000 claims description 2
108090000848 Ubiquitin Proteins 0.000 claims description 2
102000044159 Ubiquitin Human genes 0.000 claims description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
239000012190 activator Substances 0.000 claims description 2
239000011149 active material Substances 0.000 claims description 2
229940037003 alum Drugs 0.000 claims description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
101150042295 arfA gene Proteins 0.000 claims description 2
239000000440 bentonite Substances 0.000 claims description 2
229910000278 bentonite Inorganic materials 0.000 claims description 2
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 2
229910052791 calcium Inorganic materials 0.000 claims description 2
125000002091 cationic group Chemical group 0.000 claims description 2
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
108010090623 galactose binding protein Proteins 0.000 claims description 2
102000021529 galactose binding proteins Human genes 0.000 claims description 2
230000028996 humoral immune response Effects 0.000 claims description 2
238000010253 intravenous injection Methods 0.000 claims description 2
101150066555 lacZ gene Proteins 0.000 claims description 2
239000004816 latex Substances 0.000 claims description 2
229920000126 latex Polymers 0.000 claims description 2
210000002540 macrophage Anatomy 0.000 claims description 2
239000002736 nonionic surfactant Substances 0.000 claims description 2
101150087557 omcB gene Proteins 0.000 claims description 2
101150115693 ompA gene Proteins 0.000 claims description 2
101150093139 ompT gene Proteins 0.000 claims description 2
230000037361 pathway Effects 0.000 claims description 2
101150040383 pel2 gene Proteins 0.000 claims description 2
101150050446 pelB gene Proteins 0.000 claims description 2
239000002574 poison Substances 0.000 claims description 2
231100000614 poison Toxicity 0.000 claims description 2
229920000724 poly(L-arginine) polymer Polymers 0.000 claims description 2
108010011110 polyarginine Proteins 0.000 claims description 2
108010064470 polyaspartate Proteins 0.000 claims description 2
108010077051 polycysteine Proteins 0.000 claims description 2
230000003362 replicative effect Effects 0.000 claims description 2
230000002207 retinal effect Effects 0.000 claims description 2
NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 claims description 2
229940031439 squalene Drugs 0.000 claims description 2
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
210000000130 stem cell Anatomy 0.000 claims description 2
238000010254 subcutaneous injection Methods 0.000 claims description 2
239000007929 subcutaneous injection Substances 0.000 claims description 2
101150044170 trpE gene Proteins 0.000 claims description 2
241000701161 unidentified adenovirus Species 0.000 claims description 2
239000002435 venom Substances 0.000 claims description 2
231100000611 venom Toxicity 0.000 claims description 2
210000001048 venom Anatomy 0.000 claims description 2
241000272829 Cairina Species 0.000 claims 2
238000012258 culturing Methods 0.000 claims 2
210000001525 retina Anatomy 0.000 claims 2
UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 claims 1
239000000556 agonist Substances 0.000 claims 1
230000016379 mucosal immune response Effects 0.000 claims 1
230000001177 retroviral effect Effects 0.000 claims 1
208000015181 infectious disease Diseases 0.000 abstract description 28
238000011282 treatment Methods 0.000 abstract description 13
230000002265 prevention Effects 0.000 abstract description 3
206010022005 Influenza viral infections Diseases 0.000 abstract description 2
235000001014 amino acid Nutrition 0.000 description 69
235000018102 proteins Nutrition 0.000 description 67
206010072219 Mevalonic aciduria Diseases 0.000 description 55
241000699670 Mus sp. Species 0.000 description 55
239000000427 antigen Substances 0.000 description 53
108091007433 antigens Proteins 0.000 description 53
102000036639 antigens Human genes 0.000 description 53
150000007523 nucleic acids Chemical group 0.000 description 46
230000003612 virological effect Effects 0.000 description 39
210000004072 lung Anatomy 0.000 description 30
210000001519 tissue Anatomy 0.000 description 26
108020004705 Codon Proteins 0.000 description 24
102000039446 nucleic acids Human genes 0.000 description 24
108020004707 nucleic acids Proteins 0.000 description 24
108091028043 Nucleic acid sequence Proteins 0.000 description 23
108020004414 DNA Proteins 0.000 description 19
238000002255 vaccination Methods 0.000 description 19
238000002965 ELISA Methods 0.000 description 18
108050000930 Polymerase acidic proteins Proteins 0.000 description 18
101710102873 Polymerase basic protein 2 Proteins 0.000 description 18
101710085035 RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 18
230000002163 immunogen Effects 0.000 description 17
241000282898 Sus scrofa Species 0.000 description 16
238000007918 intramuscular administration Methods 0.000 description 16
241000287828 Gallus gallus Species 0.000 description 15
230000000890 antigenic effect Effects 0.000 description 15
230000037396 body weight Effects 0.000 description 15
208000037797 influenza A Diseases 0.000 description 14
230000004044 response Effects 0.000 description 13
238000006467 substitution reaction Methods 0.000 description 13
108091035707 Consensus sequence Proteins 0.000 description 12
150000001945 cysteines Chemical class 0.000 description 12
108020004999 messenger RNA Proteins 0.000 description 12
239000013612 plasmid Substances 0.000 description 12
230000010076 replication Effects 0.000 description 12
101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 description 11
-1 carrier Substances 0.000 description 11
230000002458 infectious effect Effects 0.000 description 11
235000004400 serine Nutrition 0.000 description 11
108700010070 Codon Usage Proteins 0.000 description 10
102000004127 Cytokines Human genes 0.000 description 10
108090000695 Cytokines Proteins 0.000 description 10
235000018417 cysteine Nutrition 0.000 description 10
230000004048 modification Effects 0.000 description 10
238000012986 modification Methods 0.000 description 10
230000001225 therapeutic effect Effects 0.000 description 10
241001500351 Influenzavirus A Species 0.000 description 9
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 9
230000005847 immunogenicity Effects 0.000 description 9
238000003780 insertion Methods 0.000 description 9
230000037431 insertion Effects 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 9
230000006798 recombination Effects 0.000 description 9
238000005215 recombination Methods 0.000 description 9
108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
108091034117 Oligonucleotide Proteins 0.000 description 8
230000002238 attenuated effect Effects 0.000 description 8
230000001413 cellular effect Effects 0.000 description 8
230000001086 cytosolic effect Effects 0.000 description 8
230000000694 effects Effects 0.000 description 8
230000036039 immunity Effects 0.000 description 8
210000004962 mammalian cell Anatomy 0.000 description 8
230000009467 reduction Effects 0.000 description 8
230000001105 regulatory effect Effects 0.000 description 8
230000004083 survival effect Effects 0.000 description 8
235000006576 Althaea officinalis Nutrition 0.000 description 7
210000003719 b-lymphocyte Anatomy 0.000 description 7
229940031348 multivalent vaccine Drugs 0.000 description 7
239000013641 positive control Substances 0.000 description 7
241000282412 Homo Species 0.000 description 6
108010047761 Interferon-alpha Proteins 0.000 description 6
102000006992 Interferon-alpha Human genes 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 6
238000003556 assay Methods 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 6
238000010790 dilution Methods 0.000 description 6
239000012895 dilution Substances 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
230000001965 increasing effect Effects 0.000 description 6
230000000670 limiting effect Effects 0.000 description 6
239000013642 negative control Substances 0.000 description 6
231100001160 nonlethal Toxicity 0.000 description 6
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
238000001890 transfection Methods 0.000 description 6
210000002845 virion Anatomy 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
208000031648 Body Weight Changes Diseases 0.000 description 5
102000019034 Chemokines Human genes 0.000 description 5
108010012236 Chemokines Proteins 0.000 description 5
239000008280 blood Substances 0.000 description 5
230000004579 body weight change Effects 0.000 description 5
238000001514 detection method Methods 0.000 description 5
239000010432 diamond Substances 0.000 description 5
210000003743 erythrocyte Anatomy 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
239000012678 infectious agent Substances 0.000 description 5
210000004185 liver Anatomy 0.000 description 5
238000000746 purification Methods 0.000 description 5
210000003079 salivary gland Anatomy 0.000 description 5
230000029812 viral genome replication Effects 0.000 description 5
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 4
108091093037 Peptide nucleic acid Proteins 0.000 description 4
208000037581 Persistent Infection Diseases 0.000 description 4
102100035824 Unconventional myosin-Ig Human genes 0.000 description 4
238000007792 addition Methods 0.000 description 4
RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 4
239000012620 biological material Substances 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
239000003085 diluting agent Substances 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
210000000987 immune system Anatomy 0.000 description 4
231100000636 lethal dose Toxicity 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
239000000546 pharmaceutical excipient Substances 0.000 description 4
238000012545 processing Methods 0.000 description 4
230000000069 prophylactic effect Effects 0.000 description 4
230000007017 scission Effects 0.000 description 4
238000012163 sequencing technique Methods 0.000 description 4
241000894007 species Species 0.000 description 4
238000003860 storage Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
230000005030 transcription termination Effects 0.000 description 4
238000013519 translation Methods 0.000 description 4
230000004580 weight loss Effects 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
241000283690 Bos taurus Species 0.000 description 3
241000282472 Canis lupus familiaris Species 0.000 description 3
241000283086 Equidae Species 0.000 description 3
241000282326 Felis catus Species 0.000 description 3
102000003810 Interleukin-18 Human genes 0.000 description 3
108090000171 Interleukin-18 Proteins 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
241000700559 Molluscipoxvirus Species 0.000 description 3
241000700629 Orthopoxvirus Species 0.000 description 3
241000286209 Phasianidae Species 0.000 description 3
239000012083 RIPA buffer Substances 0.000 description 3
230000005867 T cell response Effects 0.000 description 3
108020004566 Transfer RNA Proteins 0.000 description 3
241000282458 Ursus sp. Species 0.000 description 3
241000700647 Variola virus Species 0.000 description 3
239000000654 additive Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000010367 cloning Methods 0.000 description 3
239000002158 endotoxin Substances 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
210000002443 helper t lymphocyte Anatomy 0.000 description 3
238000002744 homologous recombination Methods 0.000 description 3
230000006801 homologous recombination Effects 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
230000001524 infective effect Effects 0.000 description 3
239000003550 marker Substances 0.000 description 3
229930182817 methionine Natural products 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
231100000252 nontoxic Toxicity 0.000 description 3
230000003000 nontoxic effect Effects 0.000 description 3
244000052769 pathogen Species 0.000 description 3
230000001717 pathogenic effect Effects 0.000 description 3
230000001681 protective effect Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
230000004936 stimulating effect Effects 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000009210 therapy by ultrasound Methods 0.000 description 3
238000012546 transfer Methods 0.000 description 3
241000272814 Anser sp. Species 0.000 description 2
241001274976 Bodo saltans Species 0.000 description 2
241000272834 Cairina moschata Species 0.000 description 2
241000700198 Cavia Species 0.000 description 2
241000272161 Charadriiformes Species 0.000 description 2
102000011591 Cleavage And Polyadenylation Specificity Factor Human genes 0.000 description 2
108010076130 Cleavage And Polyadenylation Specificity Factor Proteins 0.000 description 2
108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000003951 Erythropoietin Human genes 0.000 description 2
108090000394 Erythropoietin Proteins 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
241000606768 Haemophilus influenzae Species 0.000 description 2
101000763579 Homo sapiens Toll-like receptor 1 Proteins 0.000 description 2
241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
241000701806 Human papillomavirus Species 0.000 description 2
206010061598 Immunodeficiency Diseases 0.000 description 2
102000003814 Interleukin-10 Human genes 0.000 description 2
108090000174 Interleukin-10 Proteins 0.000 description 2
102000003815 Interleukin-11 Human genes 0.000 description 2
108090000177 Interleukin-11 Proteins 0.000 description 2
102000013462 Interleukin-12 Human genes 0.000 description 2
108010065805 Interleukin-12 Proteins 0.000 description 2
102000003816 Interleukin-13 Human genes 0.000 description 2
108090000176 Interleukin-13 Proteins 0.000 description 2
102000003812 Interleukin-15 Human genes 0.000 description 2
108090000172 Interleukin-15 Proteins 0.000 description 2
102000013691 Interleukin-17 Human genes 0.000 description 2
108050003558 Interleukin-17 Proteins 0.000 description 2
102000000588 Interleukin-2 Human genes 0.000 description 2
108010002350 Interleukin-2 Proteins 0.000 description 2
102000000646 Interleukin-3 Human genes 0.000 description 2
108010002386 Interleukin-3 Proteins 0.000 description 2
102000004388 Interleukin-4 Human genes 0.000 description 2
108090000978 Interleukin-4 Proteins 0.000 description 2
102000000743 Interleukin-5 Human genes 0.000 description 2
108010002616 Interleukin-5 Proteins 0.000 description 2
102000004889 Interleukin-6 Human genes 0.000 description 2
108090001005 Interleukin-6 Proteins 0.000 description 2
102000000704 Interleukin-7 Human genes 0.000 description 2
108010002586 Interleukin-7 Proteins 0.000 description 2
102000004890 Interleukin-8 Human genes 0.000 description 2
108090001007 Interleukin-8 Proteins 0.000 description 2
102000000585 Interleukin-9 Human genes 0.000 description 2
108010002335 Interleukin-9 Proteins 0.000 description 2
229930182816 L-glutamine Natural products 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
241000589920 Leptospirillum sp. Species 0.000 description 2
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 description 2
241000700560 Molluscum contagiosum virus Species 0.000 description 2
241000588653 Neisseria Species 0.000 description 2
241000700639 Parapoxvirus Species 0.000 description 2
102100039427 Polyadenylate-binding protein 2 Human genes 0.000 description 2
101710139641 Polyadenylate-binding protein 2 Proteins 0.000 description 2
108010076039 Polyproteins Proteins 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
241000700159 Rattus Species 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
102100027010 Toll-like receptor 1 Human genes 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
206010046865 Vaccinia virus infection Diseases 0.000 description 2
108010003533 Viral Envelope Proteins Proteins 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
241000700574 Yatapoxvirus Species 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
230000004913 activation Effects 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
210000000612 antigen-presenting cell Anatomy 0.000 description 2
239000002543 antimycotic Substances 0.000 description 2
229920001400 block copolymer Polymers 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
230000036755 cellular response Effects 0.000 description 2
239000013599 cloning vector Substances 0.000 description 2
230000034994 death Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
229940105423 erythropoietin Drugs 0.000 description 2
238000011049 filling Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
230000004927 fusion Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
230000035931 haemagglutination Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
230000008348 humoral response Effects 0.000 description 2
230000000899 immune system response Effects 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229940076144 interleukin-10 Drugs 0.000 description 2
229940074383 interleukin-11 Drugs 0.000 description 2
229940117681 interleukin-12 Drugs 0.000 description 2
229940076264 interleukin-3 Drugs 0.000 description 2
229940028885 interleukin-4 Drugs 0.000 description 2
229940100602 interleukin-5 Drugs 0.000 description 2
229940100601 interleukin-6 Drugs 0.000 description 2
229940100994 interleukin-7 Drugs 0.000 description 2
229940096397 interleukin-8 Drugs 0.000 description 2
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 2
229940118526 interleukin-9 Drugs 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
238000011068 loading method Methods 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
210000004779 membrane envelope Anatomy 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
230000035772 mutation Effects 0.000 description 2
DAZSWUUAFHBCGE-KRWDZBQOSA-N n-[(2s)-3-methyl-1-oxo-1-pyrrolidin-1-ylbutan-2-yl]-3-phenylpropanamide Chemical compound N([C@@H](C(C)C)C(=O)N1CCCC1)C(=O)CCC1=CC=CC=C1 DAZSWUUAFHBCGE-KRWDZBQOSA-N 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
238000005457 optimization Methods 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
150000003355 serines Chemical group 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
230000037317 transdermal delivery Effects 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
210000001944 turbinate Anatomy 0.000 description 2
208000007089 vaccinia Diseases 0.000 description 2
108700026220 vif Genes Proteins 0.000 description 2
238000001262 western blot Methods 0.000 description 2
VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
241000122170 Aliivibrio salmonicida Species 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000272813 Anser indicus Species 0.000 description 1
241000272517 Anseriformes Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241000690777 Arthrospira maxima CS-328 Species 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
101150112145 B16L gene Proteins 0.000 description 1
238000011725 BALB/c mouse Methods 0.000 description 1
241000636877 Bacillus cereus AH1134 Species 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
241000621124 Bovine papular stomatitis virus Species 0.000 description 1
101800001415 Bri23 peptide Proteins 0.000 description 1
241001508395 Burkholderia sp. Species 0.000 description 1
101800000655 C-terminal peptide Proteins 0.000 description 1
102400000107 C-terminal peptide Human genes 0.000 description 1
210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241001518976 Candidatus Pelagibacter Species 0.000 description 1
241000282421 Canidae Species 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
231100000023 Cell-mediated cytotoxicity Toxicity 0.000 description 1
206010057250 Cell-mediated cytotoxicity Diseases 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
241000282994 Cervidae Species 0.000 description 1
108091006146 Channels Proteins 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
206010008631 Cholera Diseases 0.000 description 1
241000272194 Ciconiiformes Species 0.000 description 1
241000221751 Claviceps purpurea Species 0.000 description 1
241000193449 Clostridium tetani Species 0.000 description 1
241000981532 Coprothermobacter proteolyticus DSM 5265 Species 0.000 description 1
241000759568 Corixa Species 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
241000186227 Corynebacterium diphtheriae Species 0.000 description 1
241000700626 Cowpox virus Species 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
241000938605 Crocodylia Species 0.000 description 1
241000673115 Cryptosporidium hominis Species 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
101150083809 D10L gene Proteins 0.000 description 1
101150116298 D12L gene Proteins 0.000 description 1
101150044623 D13L gene Proteins 0.000 description 1
238000012270 DNA recombination Methods 0.000 description 1
241000710827 Dengue virus 1 Species 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
206010061818 Disease progression Diseases 0.000 description 1
241000122787 Drosophila montana Species 0.000 description 1
241000725630 Ectromelia virus Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
241000283074 Equus asinus Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241001646719 Escherichia coli O157:H7 Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
241000850745 Francisella tularensis subsp. novicida FTG Species 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
241000282818 Giraffidae Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 1
108060003393 Granulin Proteins 0.000 description 1
206010018693 Granuloma inguinale Diseases 0.000 description 1
241000606790 Haemophilus Species 0.000 description 1
241000853480 Helicobacter pylori G27 Species 0.000 description 1
241000768840 Helicoverpa armigera SNPV Species 0.000 description 1
241000711549 Hepacivirus C Species 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
241000709721 Hepatovirus A Species 0.000 description 1
241001272567 Hominoidea Species 0.000 description 1
101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
101000998953 Homo sapiens Immunoglobulin heavy variable 1-2 Proteins 0.000 description 1
101000762967 Homo sapiens Lymphokine-activated killer T-cell-originated protein kinase Proteins 0.000 description 1
101000706243 Homo sapiens Prominin-2 Proteins 0.000 description 1
241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102100036887 Immunoglobulin heavy variable 1-2 Human genes 0.000 description 1
241000711450 Infectious bronchitis virus Species 0.000 description 1
241000362996 Influenza A virus (A/Guinea fowl/New York/101276-1/2005(H7N2)) Species 0.000 description 1
241000852401 Influenza A virus (A/Myanmar/M187/2007(H3N2)) Species 0.000 description 1
241000471241 Influenza A virus (A/Pennsylvania/PIT25/2008(H3N2)) Species 0.000 description 1
241000889889 Influenza A virus (A/chicken/Iran/16/2000(H9N2)) Species 0.000 description 1
241000887640 Influenza A virus (A/mallard/MN/1/2000(H5N2)) Species 0.000 description 1
241000852381 Influenza B virus (B/Myanmar/M170/2007) Species 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000049772 Interleukin-16 Human genes 0.000 description 1
101800003050 Interleukin-16 Proteins 0.000 description 1
102100039898 Interleukin-18 Human genes 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
241000448678 Intestinibacter bartlettii DSM 16795 Species 0.000 description 1
108090000862 Ion Channels Proteins 0.000 description 1
102000004310 Ion Channels Human genes 0.000 description 1
241000588748 Klebsiella Species 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
241000256492 Laccaria bicolor S238N-H82 Species 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241000222722 Leishmania <genus> Species 0.000 description 1
HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
108010028921 Lipopeptides Proteins 0.000 description 1
102100026753 Lymphokine-activated killer T-cell-originated protein kinase Human genes 0.000 description 1
102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
241000712079 Measles morbillivirus Species 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
241000700627 Monkeypox virus Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
101100512532 Mus musculus Atf7ip2 gene Proteins 0.000 description 1
101100481581 Mus musculus Tlr13 gene Proteins 0.000 description 1
241000204048 Mycoplasma hominis Species 0.000 description 1
GUVMFDICMFQHSZ-UHFFFAOYSA-N N-(1-aminoethenyl)-1-[4-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[hydroxy-[[3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-[[hydroxy-[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylimidazole-4-carboxamide Chemical group CC1=C(C(=O)NC(N)=C)N=CN1C1OC(COP(O)(=S)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)CO)C(OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)O)C1 GUVMFDICMFQHSZ-UHFFFAOYSA-N 0.000 description 1
108010079364 N-glycylalanine Proteins 0.000 description 1
MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
101150118742 NP gene Proteins 0.000 description 1
101150073111 NPH1 gene Proteins 0.000 description 1
241001272871 Nitrosococcus oceani C-27 Species 0.000 description 1
241000272458 Numididae Species 0.000 description 1
241000700635 Orf virus Species 0.000 description 1
241000712464 Orthomyxoviridae Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
241000282579 Pan Species 0.000 description 1
241000282320 Panthera leo Species 0.000 description 1
241000282376 Panthera tigris Species 0.000 description 1
206010033976 Paravaccinia Diseases 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000002508 Peptide Elongation Factors Human genes 0.000 description 1
108010068204 Peptide Elongation Factors Proteins 0.000 description 1
241000871928 Peromyscus californicus insignis Species 0.000 description 1
241001263503 Piromyces rhizinflatus Species 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
241001252411 Polynucleobacter necessarius Species 0.000 description 1
241000282405 Pongo abelii Species 0.000 description 1
241000700625 Poxviridae Species 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102100031190 Prominin-2 Human genes 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
241000621172 Pseudocowpox virus Species 0.000 description 1
241000700638 Raccoonpox virus Species 0.000 description 1
241000437800 Rhodobacterales bacterium Species 0.000 description 1
102000004389 Ribonucleoproteins Human genes 0.000 description 1
108010081734 Ribonucleoproteins Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000710799 Rubella virus Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
241001136583 Solanum pennellii Species 0.000 description 1
235000011564 Solanum pennellii Nutrition 0.000 description 1
241000008793 Staphylococcus phage phi2958PVL Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
108700011201 Streptococcus IgG Fc-binding Proteins 0.000 description 1
241000193998 Streptococcus pneumoniae Species 0.000 description 1
241000187419 Streptomyces rimosus Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000282887 Suidae Species 0.000 description 1
241001639503 Sulfurimonas gotlandica GD1 Species 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
101150003725 TK gene Proteins 0.000 description 1
241000404000 Tanapox virus Species 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
241000422914 Tetraodon nigroviridis Species 0.000 description 1
241000857763 Thermodesulfovibrio yellowstonii DSM 11347 Species 0.000 description 1
241000101044 Tomato torrado virus Species 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
241000589884 Treponema pallidum Species 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
241000202921 Ureaplasma urealyticum Species 0.000 description 1
241000736774 Uria aalge Species 0.000 description 1
101100076195 Vaccinia virus (strain Western Reserve) VACWR117 gene Proteins 0.000 description 1
101100498120 Vaccinia virus (strain Western Reserve) VACWR118 gene Proteins 0.000 description 1
101900244976 Vaccinia virus Interferon antagonist K1L Proteins 0.000 description 1
101100219276 Variola virus (isolate Human/India/Ind3/1967) C4L gene Proteins 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
108010065667 Viral Matrix Proteins Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
241001536558 Yaba monkey tumor virus Species 0.000 description 1
229920000392 Zymosan Polymers 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
230000004075 alteration Effects 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000003321 amplification Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000001857 anti-mycotic effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
210000000576 arachnoid Anatomy 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
241001270754 beta proteobacterium KB13 Species 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
210000001736 capillary Anatomy 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
210000005242 cardiac chamber Anatomy 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
230000005890 cell-mediated cytotoxicity Effects 0.000 description 1
230000005889 cellular cytotoxicity Effects 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000008602 contraction Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000009223 counseling Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
230000005750 disease progression Effects 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
210000001174 endocardium Anatomy 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000000688 enterotoxigenic effect Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
231100000776 exotoxin Toxicity 0.000 description 1
239000002095 exotoxin Substances 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
108700014844 flt3 ligand Proteins 0.000 description 1
101150023663 flu gene Proteins 0.000 description 1
239000012530 fluid Substances 0.000 description 1
210000000232 gallbladder Anatomy 0.000 description 1
210000005095 gastrointestinal system Anatomy 0.000 description 1
230000007614 genetic variation Effects 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
230000000762 glandular Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000001727 glucose Nutrition 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
229940045808 haemophilus influenzae type b Drugs 0.000 description 1
210000002837 heart atrium Anatomy 0.000 description 1
210000005003 heart tissue Anatomy 0.000 description 1
210000001308 heart ventricle Anatomy 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
230000004727 humoral immunity Effects 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
210000001822 immobilized cell Anatomy 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
210000004201 immune sera Anatomy 0.000 description 1
229940042743 immune sera Drugs 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
108700010900 influenza virus proteins Proteins 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
108010045648 interferon omega 1 Proteins 0.000 description 1
108700027921 interferon tau Proteins 0.000 description 1
229960001388 interferon-beta Drugs 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000007914 intraventricular administration Methods 0.000 description 1
101150028555 ksi gene Proteins 0.000 description 1
239000008101 lactose Substances 0.000 description 1
229960001614 levamisole Drugs 0.000 description 1
239000003446 ligand Substances 0.000 description 1
229920006008 lipopolysaccharide Polymers 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
230000001926 lymphatic effect Effects 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
244000000010 microbial pathogen Species 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
210000003928 nasal cavity Anatomy 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
229940096978 oral tablet Drugs 0.000 description 1
239000007935 oral tablet Substances 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
229960005030 other vaccine in atc Drugs 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
102000044160 oxysterol binding protein Human genes 0.000 description 1
108010040421 oxysterol binding protein Proteins 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
210000004923 pancreatic tissue Anatomy 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000007918 pathogenicity Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
210000003516 pericardium Anatomy 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
229940023488 pill Drugs 0.000 description 1
239000006187 pill Substances 0.000 description 1
229920002851 polycationic polymer Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
230000001124 posttranscriptional effect Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
229940023867 prime-boost vaccine Drugs 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000001915 proofreading effect Effects 0.000 description 1
229940021993 prophylactic vaccine Drugs 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
239000001397 quillaja saponaria molina bark Substances 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
210000005084 renal tissue Anatomy 0.000 description 1
238000009877 rendering Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000012552 review Methods 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
230000001932 seasonal effect Effects 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
125000005629 sialic acid group Chemical group 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
239000002884 skin cream Substances 0.000 description 1
239000008247 solid mixture Substances 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
229940031000 streptococcus pneumoniae Drugs 0.000 description 1
210000002330 subarachnoid space Anatomy 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
231100000617 superantigen Toxicity 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
230000008685 targeting Effects 0.000 description 1
230000002381 testicular Effects 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000003151 transfection method Methods 0.000 description 1
239000012096 transfection reagent Substances 0.000 description 1
230000005945 translocation Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
210000003501 vero cell Anatomy 0.000 description 1
230000007444 viral RNA synthesis Effects 0.000 description 1
230000017613 viral reproduction Effects 0.000 description 1
230000006490 viral transcription Effects 0.000 description 1
230000001018 virulence Effects 0.000 description 1
239000013585 weight reducing agent Substances 0.000 description 1
101150069452 z gene Proteins 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1